-
公开(公告)号:EP4374877A2
公开(公告)日:2024-05-29
申请号:EP24161259.7
申请日:2015-09-11
发明人: Ohtake, Yoshihito , Okamoto, Naoki , Ono, Yoshiyuki , Kashiwagi, Hirotaka , Kimbara, Atsushi , Harada, Takeo , Hori, Nobuyuki , Murata, Yoshihisa , Tachibana, Kazutaka , Tanaka, Shota , Nomura, Kenichi , Ide, Mitsuaki , Mizuguchi, Eisaku , Ichida, Yasuhiro , Ohtomo, Shuichi , Horiba, Naoshi
IPC分类号: A61K45/06
CPC分类号: C07D403/12 , C07D405/14 , C07D413/14 , A61K45/00 , A61K31/19 , A61K31/4545 , A61K31/50 , A61K31/501 , A61K31/5025 , A61K31/503 , A61K31/506 , A61K31/537 , A61K31/5377 , A61K31/734 , A61K33/08 , A61K33/10 , A61K33/24 , A61K33/26 , C07D401/06 , C07D401/12 , C07D237/04 , C07D403/14 , C07D471/04 , C07D487/04 , C07D487/08 , C07D498/08 , A61K33/244 , A61K45/06 , A61K31/24
摘要: The present invention provides a pharmaceutical composition containing, as an active ingredient, a dihydropyridazine-3,5-dione derivative or a salt thereof or a solvate of these, wherein the composition is administered in combination with a phosphorus adsorbent.
-
公开(公告)号:EP4374877A3
公开(公告)日:2024-07-17
申请号:EP24161259.7
申请日:2015-09-11
发明人: Ohtake, Yoshihito , Okamoto, Naoki , Ono, Yoshiyuki , Kashiwagi, Hirotaka , Kimbara, Atsushi , Harada, Takeo , Hori, Nobuyuki , Murata, Yoshihisa , Tachibana, Kazutaka , Tanaka, Shota , Nomura, Kenichi , Ide, Mitsuaki , Mizuguchi, Eisaku , Ichida, Yasuhiro , Ohtomo, Shuichi , Horiba, Naoshi
IPC分类号: A61K31/50 , A61K31/19 , A61K31/4545 , A61K31/501 , A61K31/5025 , A61K31/503 , A61K31/506 , A61K31/537 , A61K31/5377 , A61K31/734 , A61K33/08 , A61K33/10 , A61K33/24 , A61K33/26 , A61K45/00 , A61P3/12 , A61P5/18 , A61P9/10 , A61P13/12 , A61P43/00
CPC分类号: C07D403/12 , C07D405/14 , C07D413/14 , A61K45/00 , A61K31/19 , A61K31/4545 , A61K31/50 , A61K31/501 , A61K31/5025 , A61K31/503 , A61K31/506 , A61K31/537 , A61K31/5377 , A61K31/734 , A61K33/08 , A61K33/10 , A61K33/24 , A61K33/26 , C07D401/06 , C07D401/12 , C07D237/04 , C07D403/14 , C07D471/04 , C07D487/04 , C07D487/08 , C07D498/08 , A61K33/244 , A61K45/06 , A61K31/24 , A61P13/12
摘要: The present invention provides a pharmaceutical composition containing, as an active ingredient, a dihydropyridazine-3,5-dione derivative or a salt thereof or a solvate of these, wherein the composition is administered in combination with a phosphorus adsorbent.
-